choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Augmentin

Augmentin Newsletter
  • Rs 233 Crore in 6 Months: Mounjaro Becomes India's Second-Biggest Drug by Sales 10 Oct 2025 21:27 GMT

    … Originally developed as a treatment for type 2 diabetes, … traction among patients and doctors for its dual-action … urban patients. By comparison, Augmentin, India’s top-selling … Advantage Unlike traditional diabetes medications, Mounjaro mimics two hormones …

  • Eli Lilly’s weight-loss drug Mounjaro races to second spot in India’s pharma market 08 Oct 2025 11:29 GMT

    … ’s diabetes and weight-loss drug Mounjaro has taken India’s … - just behind GSK’s Augmentin at ₹85 crore and ahead … ’s ₹750-crore anti-obesity drug market. In a country often … shift as millions turn to medication to manage weight and glucose …

  • Weight Loss Drug Mounjaro Registers Rs 80 Cr Sales 08 Oct 2025 03:49 GMT

    … selling drug for the month was GlaxoSmithKline's Augmentin, … ) at Pharmarack. The drug is currently available in two … as Lilly received Central Drugs Standard Control Organisation (CDSCO … -loss treatments. According to an Indian Council of Medical Research …

  • Eli Lilly's obesity drug Mounjaro's India sales hit a sweet spot within six months of launch 08 Oct 2025 00:07 GMT

    … and diabetes drug Mounjaro has stunned the Indian pharmaceutical market, rising … trailing the legacy antibiotic brand Augmentin (₹85 crore) and … pre-filled with the drug. Meanwhile, Wegovy sales have … way to administer the medicine. The pens are available …

  • ADH faces medicine shortage; emergency local purchase approved 21 Sep 2025 03:17 GMT

    … inconvenience to both patients and doctors. Hospital officials confirmed on Saturday … tablets, Diclofenac tablets, Cefixime tablets, Augmentin tablets, and cough syrup. In … treatment at a government hospital, but had to spend money on medicines

  • Tinubu urged to implement executive order on affordable medicines 01 Sep 2025 09:41 GMT

    … burden of patients regarding drug prices, which was signed … Oyintiloye, prices of critical drugs such as insulin, Metformin, … while prices of medicines such as Augmentin and Ventolin inhaler have … of the executive order, drug prices continued to soar. …

  • ‘Drugs Too Expensive In Nigeria’ – APC Chieftain Tells Tinubu 31 Aug 2025 13:18 GMT

    … reducing prices of medical consumables, many life-saving drugs are still priced … production costs and boost local pharmaceutical competitiveness, had not translated into … recorded in the prices of Augmentin and Ventolin inhalers. Oyintiloye urged …

  • Implement executive order on drug prices, APC chieftain urges Tinubu 31 Aug 2025 11:57 GMT

    … patients regarding drug prices, many life-saving drugs are still … of the executive order, drug prices have continued to soar … while prices of medicines such as Augmentin and Ventolin inhalers … local manufacturers to reduce drug prices. The APC chieftain …

  • 143 drugs fail CDSCO quality test in July; 8 samples flagged as spurious 28 Aug 2025 17:51 GMT

    … Venclyxto Tablets, Deca-Durabolin, Thrombophob, Augmentin, PAN 40, Clavam 625, and … Indian pharmaceutical companies. Meanwhile, the NSQ list includes several widely used medicines … vitamin supplements, and other common drugs. While the Health Ministry issued …

  • Sick and Stranded: Tinubu’s Drug Price Order Yet to Ease Nigerians’ Burden 25 Aug 2025 15:49 GMT

    … on items such as Active Pharmaceutical Ingredients (APIs), excipients, syringes … show that most essential medicines now cost significantly more. … ₦60,000. For malaria treatment, the situation is even … a handful of drugs bucked the trend: Augmentin dropped by …

Satisfied with the content?

Continue to create your account.